NERV
NERV
NASDAQ · Biotechnology

Minerva Neurosciences Inc

$4.80
+0.58 (+13.74%)
As of Feb 8, 2:05 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 21.71M 21.78M 21.76M
Net Income 4.38M 3.81M 4.44M
EPS
Profit Margin 20.2% 17.5% 20.4%
Rev Growth +1.1% -8.2% +18.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 63.21M 59.57M 73.18M
Total Equity 126.47M 118.93M 120.51M
D/E Ratio 0.50 0.50 0.61
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 6.15M 6.17M 6.37M
Free Cash Flow 3.82M 4.48M 4.63M